|
|||||
|
|
Docetaxel,gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer |
|
| Authors: | E. Kontopodis N. Kentepozidis Ch. Christophyllakis I. Boukovinas A. Kalykaki K. Kalbakis L. Vamvakas S. Agelaki A. Kotsakis N. Vardakis V. Georgoulias D. Mavroudis |
| Affiliation: | 1. Hellenic Oncology Research Group (HORG), 55 Lomvardou Str, 11474, Athens, Greece 2. Department of Medical Oncology, University General Hospital of Heraklion, Voutes, 71110, Heraklion, Crete, Greece |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |